Pre-order Enquiry
Request Free Sample
Global and China Benign Prostatic Hyperplasia (BPH) Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-18974672 | Publishing Date : 25-Aug-2021 | No. of pages : 106
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and China Benign Prostatic Hyperplasia (BPH) Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Perspective (2016-2027)
2.2 Benign Prostatic Hyperplasia (BPH) Treatment Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Benign Prostatic Hyperplasia (BPH) Treatment Industry Dynamic
2.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Market Trends
2.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
2.3.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
2.3.4 Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue
3.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue (2016-2021)
3.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia (BPH) Treatment Revenue
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio
3.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2020
3.5 Benign Prostatic Hyperplasia (BPH) Treatment Key Players Head office and Area Served
3.6 Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
3.7 Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Type
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2022-2027)
5 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Application
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2016-2027)
6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
6.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021)
6.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027)
6.2.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2027)
6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
6.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021)
6.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027)
6.3.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2027)
6.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
6.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021)
6.4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2016-2027)
7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
7.2.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2027)
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
7.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2027)
7.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
7.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
8.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
8.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region
8.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2016-2027)
9.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
9.2.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2027)
9.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
9.3.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2027)
9.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
9.4.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
10.2.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
10.3.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
10.4.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.1.4 Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.2.4 Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.4.4 Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.4.5 Boston Scientific Recent Development
11.5 Teleflex
11.5.1 Teleflex Company Details
11.5.2 Teleflex Business Overview
11.5.3 Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.5.4 Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.5.5 Teleflex Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Details
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.6.4 Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.6.5 Cardinal Health Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.7.4 Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.7.5 Allergan Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.9.4 Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.10.4 Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
11.10.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Benign Prostatic Hyperplasia (BPH) Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Devices
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Regions (2016-2021)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Regions (2022-2027)
Table 10. Benign Prostatic Hyperplasia (BPH) Treatment Market Trends
Table 11. Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
Table 12. Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
Table 13. Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2020)
Table 17. Ranking of Global Top Benign Prostatic Hyperplasia (BPH) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
Table 21. Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 64. Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 69. Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 74. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 79. Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Teleflex Company Details
Table 82. Teleflex Business Overview
Table 83. Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 84. Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 85. Teleflex Recent Development
Table 86. Cardinal Health Company Details
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 89. Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 90. Cardinal Health Recent Development
Table 91. Allergan Company Details
Table 92. Allergan Business Overview
Table 93. Allergan Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 94. Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 95. Allergan Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 103. Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 104. Mylan Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 108. Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Devices Features
Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Benign Prostatic Hyperplasia (BPH) Treatment Report Years Considered
Figure 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Regions (2022-2027)
Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Players in 2020
Figure 14. Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2020
Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2016-2027)
Figure 20. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2016-2027)
Figure 21. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Country (2016-2027)
Figure 22. United States Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2016-2027)
Figure 26. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2016-2027)
Figure 27. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Country (2016-2027)
Figure 28. Germany Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region (2016-2027)
Figure 38. China Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 58. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 60. Boston Scientific Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 61. Teleflex Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 62. Cardinal Health Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global and China Benign Prostatic Hyperplasia (BPH) Treatment Market Size, Status and Forecast 2021-2027
PfizerSanofi
GlaxoSmithKline
Boston Scientific
Teleflex
Cardinal Health
Allergan
Teva Pharmaceutical
Mylan
Eli Lilly
